PART I Forward-Looking Statements Unless the context indicates otherwise, as used in this Annual Report, the terms Nika, we, us, our, our company and our business refer, to Nika Pharmaceuticals, Inc.., including its subsidiaries. Certain statements, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives, and expected operating results, and the assumptions upon which those statements are based, are forward-looking statemen...
Q2 FY2026 — expected 2026-09-24
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-25 | 2025-12-31 | 0001826466-26-000026 | EDGAR | 16K words |
| 2025-03-31 | 2024-12-31 | 0001826466-25-000030 | EDGAR | — |
| 2024-04-01 | 2023-12-31 | 0001826466-24-000041 | EDGAR | — |
| 2023-04-10 | 2022-12-31 | 0001826466-23-000014 | EDGAR | — |
| 2022-03-03 | 2021-12-31 | 0001826466-22-000017 | EDGAR | — |
| 2021-03-24 | 2020-12-31 | 0001826466-21-000075 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-10 | 2026-06-30 | 0001826466-26-000049 | EDGAR | — |
| 2025-11-07 | 2025-09-30 | 0001826466-25-000096 | EDGAR | 10K words |
| 2025-08-14 | 2025-06-30 | 0001826466-25-000087 | EDGAR | — |
| 2025-05-13 | 2025-03-31 | 0001826466-25-000058 | EDGAR | — |
| 2024-11-12 | 2024-09-30 | 0001826466-24-000146 | EDGAR | — |
| 2024-09-18 | 2024-06-30 | 0001826466-24-000120 | EDGAR | — |
| 2024-05-28 | 2024-03-31 | 0001826466-24-000068 | EDGAR | — |
| 2023-10-31 | 2023-09-30 | 0001826466-23-000038 | EDGAR | — |
| 2023-08-21 | 2023-06-30 | 0001826466-23-000031 | EDGAR | — |
| 2023-05-15 | 2023-03-31 | 0001826466-23-000022 | EDGAR | — |
| 2022-11-10 | 2022-09-30 | 0001826466-22-000142 | EDGAR | — |
| 2022-08-22 | 2022-06-30 | 0001826466-22-000111 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2024-10-16 | 0001826466-24-000131 | EDGAR | 0K words |
| 2024-10-01 | 0001826466-24-000128 | EDGAR | — |
| 2024-08-27 | 0001826466-24-000096 | EDGAR | — |
| 2024-05-10 | 0001826466-24-000056 | EDGAR | — |
| 2024-04-15 | 0001826466-24-000050 | EDGAR | — |
| 2024-03-05 | 0001826466-24-000020 | EDGAR | — |
| 2024-02-16 | 0001826466-24-000005 | EDGAR | — |
| 2023-09-18 | 0001826466-23-000033 | EDGAR | — |
| 2022-11-15 | 0001826466-22-000149 | EDGAR | — |
| 2022-11-01 | 0001826466-22-000112 | EDGAR | — |
38 total filings indexed. 10 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001145604 |
| Ticker | NIKA |
| Exchange | OTC |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | CO |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/NIKA (~200 tokens, structured JSON with cryptographic provenance)